Analytical treatment interruptions in HIV cure research

This webinar will provide the latest updates on analytical treatment interruptions (ATIs) and their role in HIV cure research. It will highlight the ethical implications of ATIs, as well as summarize key messages from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Cure Trials. Participants will also hear updates on paediatric HIV cure research, with a focus on data from the IMPAACT P1115 study and the challenges for ATIs in a paediatric population in low- and middle-income countries from the perspective of care providers.

Moderators:

• Sharon Lewin, Director, Doherty Institute for Infection and Immunity, University of Melbourne, Australia, and IAS President
• Josephine Nabukenya, Founder and Executive Director, Miles of Smiles Foundation, Uganda, and IAS Governing Council Member

Confirmed speakers include:

• Jillian Lau, infectious diseases physician, Royal Melbourne Hospital and Alfred Hospital, Australia
• Deborah Persaud, Professor, Pediatrics Infectious Disease, Johns Hopkins University School of Medicine, USA
• Adeodata Kekitiinwa, Clinical Research Site Leader, Investigator of Record, IMPAACT P1115 and IMPAACT 2028 and Chief Investigator Breather Plus, Baylor College of Medicine Children’s Foundation, Uganda
• Violet Korutaro, IMPAACT early-career investigator, Baylor College of Medicine Children’s Foundation, Uganda